Cargando…

Cyclophosphamide induces durable molecular and clinical responses in patients with relapsed T-LGL leukemia

Detalles Bibliográficos
Autores principales:	Braunstein, Zachary, McLaughlin, Eric, Mishra, Anjali, Brammer, Jonathan E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043937/ https://www.ncbi.nlm.nih.gov/pubmed/34996100 http://dx.doi.org/10.1182/bloodadvances.2021006263

Ejemplares similares

Cyclophosphamide as a first-line therapy in LGL leukemia
por: Moignet, A, et al.
Publicado: (2014)

Florid Pulmonary Mycobacterium avium-intracellulare Infection in a Patient With Large Granular Lymphocytic (LGL) Leukemia on Chronic Cyclophosphamide
por: Kojadinovic, Arsenije, et al.
Publicado: (2021)

A case of LGL leukemia with paucity of erythropoiesis
por: Razavi, Habib M.
Publicado: (2020)

A guilt-by-association mutation network in LGL leukemia
por: Andersson, Emma I., et al.
Publicado: (2017)

Retrovirus insertion site analysis of LGL leukemia patient genomes
por: Li, Weiling, et al.
Publicado: (2019)

STAT5b in LGL leukemia – a novel therapeutic target?
por: Rajala, Hanna L. M., et al.
Publicado: (2013)

Emergence of a STAT3 mutated NK clone in LGL leukemia
por: Yan, Yiyi, et al.
Publicado: (2014)

STAT3 mutation impacts biological and clinical features of T-LGL leukemia
por: Teramo, Antonella, et al.
Publicado: (2017)

STAT5B(N642H) drives transformation of NKT cells: a novel mouse model for CD56(+) T-LGL leukemia
por: Klein, Klara, et al.
Publicado: (2019)

Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas
por: Braunstein, Zachary, et al.
Publicado: (2022)

Are T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder Really Two Distinct Diseases?
por: Zambello, Renato, et al.
Publicado: (2014)

Inhibition of glioblastoma malignancy by Lgl1
por: Gont, Alexander, et al.
Publicado: (2014)

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma
por: Pro, Barbara, et al.
Publicado: (2016)

BLNK mutation associated with T-cell LGL leukemia and autoimmune diseases: Case report in hematology
por: Fouquet, Guillemette, et al.
Publicado: (2022)

LGL leukemia patients exhibit substantial protective humoral responses following SARS‐CoV‐2 vaccination
por: Cheon, Heejin, et al.
Publicado: (2022)

Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias
por: Braunstein, Zachary, et al.
Publicado: (2022)

Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
por: Herling, Marco, et al.
Publicado: (2022)

dbLGL: an online leukemia gene and literature database for the retrospective comparison of adult and childhood leukemia genetics with literature evidence
por: Liu, Yining, et al.
Publicado: (2018)

Durable response to mTOR inhibition in a patient with relapsing papillary tumor of the pineal region
por: Belting, Mattias, et al.
Publicado: (2019)

Cytokines in the Pathogenesis of Large Granular Lymphocytic Leukemia
por: Isabelle, Colleen, et al.
Publicado: (2022)

Involvement of Lgl and Mahjong/VprBP in Cell Competition
por: Tamori, Yoichiro, et al.
Publicado: (2010)

Molecular Expression of the Scribble Complex Genes, Dlg, Scrib and Lgl, in Silkworm, Bombyx mori
por: Qi, Hai-Sheng, et al.
Publicado: (2013)

T-cell large granular lymphocytic (LGL) leukemia consists of CD4(+)/CD8(dim) and CD4(-)/CD8(+) LGL populations in association with immune thrombocytopenia, autoimmune neutropenia, and monoclonal B-cell lymphocytosis
por: Kuwahara, Naoya, et al.
Publicado: (2019)

Successful treatment of cerebral aspergillosis: case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL)
por: Turki, Amin T., et al.
Publicado: (2017)

Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma
por: Blanchette, P., et al.
Publicado: (2012)

Lgl1 Is Required for Olfaction and Development of Olfactory Bulb in Mice
por: Li, Zhenzu, et al.
Publicado: (2016)

Toward a Better Classification System for NK-LGL Disorders
por: Drillet, Gaëlle, et al.
Publicado: (2022)

Large granular lymphocytes (LGL) in primary Sjögren syndrome (pSS): immunophenotype and review on the pathological role of T cells in pSS
por: Tavarozzi, Rita, et al.
Publicado: (2020)

Tumor suppressor protein Lgl mediates G1 cell cycle arrest at high cell density by forming an Lgl-VprBP-DDB1 complex
por: Yamashita, Kazunari, et al.
Publicado: (2015)

Metronomic regimen as an effective treatment for aggressive T-LGL leukemia with central nervous system infiltration: clinical experience and review of literature
por: Liu, Yun, et al.
Publicado: (2017)

Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001
por: Janssen, Luca L.G., et al.
Publicado: (2023)

75. Relapsing polychondritis with tracheal involvement: responsive to induction cyclophosphamide therapy
por: Solaiman, Mohammad, et al.
Publicado: (2018)

Notch signals modulate lgl mediated tumorigenesis by the activation of JNK signaling
por: Paul, Maimuna Sali, et al.
Publicado: (2018)

penner/lgl2 is required for the integrity of the photoreceptor layer in the zebrafish retina
por: Kujawski, Satu, et al.
Publicado: (2019)

Correction: Lgl1 Is Required for Olfaction and Development of Olfactory Bulb in Mice
por: Li, Zhenzu, et al.
Publicado: (2017)

Small-Sized Clone of T Cells in Multiple Myeloma Patient after Auto-SCT: T-LGL Leukemia Type or Clonal T-Cell Aberration?
por: Mele, Giuseppe, et al.
Publicado: (2013)

Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations
por: Ferrari, Anna, et al.
Publicado: (2023)

Durability of and role of AKT in FGF7p urothelial protection against cyclophosphamide
por: Narla, Sridhar Tatarao, et al.
Publicado: (2022)

Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax
por: Niswander, Lisa M., et al.
Publicado: (2023)

Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia
por: Rapaport, Franck, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_is8ctv8tajknamavdfl48s80fh